Xtalic Corporation – Trademark Portfolio

Entity Type: 03

Xtalic Corporation holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 2 (Paints) — 17 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 2 Nice Classification classes. Currently, 9 trademarks are registered and 2 are pending. Notable registered marks include LUNA, PALLEX, XTALIC, XENERGY, and XTALIUM. The owner is based in Marlborough, MA.

260 Cedar Hill Street

Marlborough, MA 01752

18 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Xtalic Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

2
Paints (17 filings)

Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Xtalic Corporation have?

Xtalic Corporation has 18 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 pending, 7 abandoned.

What trademark classes does Xtalic Corporation file in?

Xtalic Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 2 (Paints), Class 14 (Jewelry). Class 2 covers paints, varnishes, lacquers; preservatives against rust and against deterioration of wood.

What are Xtalic Corporation's most well-known trademarks?

Xtalic Corporation's registered trademark portfolio includes well-known marks such as LUNA, PALLEX, XTALIC, XENERGY, and XTALIUM. These are among 9 currently registered trademarks in the portfolio.

What is Xtalic Corporation's trademark registration success rate?

Xtalic Corporation has a 56% trademark registration rate, with 9 out of 16 resolved applications resulting in successful registration. Currently, 2 applications are pending review.